Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis

Abstract

Immunoglobulin type gamma 4 (IgG4)-related disease is a relatively newly described clinical entity characterized by a distinctive histopathological appearance, increased numbers of IgG4 positive plasma cells and often, but not always, elevated serum IgG4 concentrations. The most common renal manifestation of IgG4-related disease is tubulointerstitial… (More)
DOI: 10.1097/MD.0000000000001366

Topics

2 Figures and Tables

Cite this paper

@inproceedings{McMahon2015RituximabFT, title={Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis}, author={Blaithin A McMahon and Tessa K Novick and Paul J. Scheel and Serena M. Bagnasco and Mohamed G. Atta and Hajji. Raouf}, booktitle={Medicine}, year={2015} }